Browsing by Author "Masaomi Nangaku"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- PublicationCapturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes(2020)
;Roberto Pecoits-Filho ;Ikechi G. Okpechi ;Jo-Ann Donner ;David C.H. Harris ;Harith M. Aljubori ;Aminu K. Bello ;Ezequiel Bellorin-Font ;Fergus J. Caskey ;Allan Collins ;Alfonso M. Cueto-Manzano ;John Feehally ;Bak Leong Goh ;Kitty J. Jager ;Masaomi Nangaku ;Muhibur Rahman ;Manisha Sahay ;Abdulkarim Saleh ;Laura Sola ;Rumeyza Turan Kazancioglu ;Rachael C. Walker ;Robert Walker ;Qiang Yao ;Xueqing Yu ;Ming-Hui ZhaoDavid W. JohnsonA large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes - PublicationGlobal case studies for chronic kidney disease/end-stage kidney disease care(2020)
;Chih-Wei Yang ;David C.H. Harris ;Valerie A. Luyckx ;Masaomi Nangaku ;Fan Fan Hou ;Guillermo Garcia Garcia ;Hasan Abu-Aisha ;Abdou Niang ;Laura Sola ;Sakarn Bunnag ;Somchai Eiam-Ong ;Kriang Tungsanga ;Marie Richards ;Nick Richards ;Bak Leong Goh ;Gavin Dreyer ;Rhys Evans ;Henry Mzingajira ;Ahmed Twahir ;Mignon I. McCulloch ;Curie Ahn ;Charlotte Osafo ;Hsiang-Hao Hsu ;Lianne Barnieh ;Jo-Ann DonnerMarcello TonelliThe prevalence of chronic kidney disease and its risk factors is increasing worldwide, and the rapid rise in global need for end-stage kidney disease care is a major challenge for health systems, particularly in low- and middle-income countries. Countries are responding to the challenge of end-stage kidney disease in different ways, with variable provision of the components of a kidney care strategy, including effective prevention, detection, conservative care, kidney transplantation, and an appropriate mix of dialysis modalities. This collection of case studies is from 15 countries from around the world and offers valuable learning examples from a variety of contexts. The variability in approaches may be explained by country differences in burden of disease, available human or financial resources, income status, and cost structures. In addition, cultural considerations, political context, and competing interests from other stakeholders must be considered. Although the approaches taken have often varied substantially, a common theme is the potential benefits of multistakeholder engagement aimed at improving the availability and scope of integrated kidney care.